Search the Newsreel

What To Expect From Boston Scientific’s (BSX) Q2 Earnings

What To Expect From Boston Scientific's (BSX) Q2 Earnings Medical device company Boston Scientific (NYSE:BSX) will be reporting earnings this Wednesday morning. Here's what to expect. Boston Scientific beat analysts' revenue expectations last quarter, reporting revenues of $5.20 billion, up 11.6% year on year. …

Boston Scientific Restructuring To Trim Workforce

(RTTNews) - Boston Scientific Corp (BSX) has unveiled a sweeping global restructuring program, according to its Form 8-K filing with the U.S. Securities and Exchange Commission. The plan, approved by the board of directors, is designed to streamline operations, optimize supply chains, and align …

Boston Scientific unveils new restructuring plan, expects job cuts

July 27 (Reuters) - Boston Scientific's board has approved a new company-wide restructuring plan aimed at ‌cutting costs and to better position the ‌company for future growth, the medical device maker said in a ​regulatory filing on Monday. Here are some details: • The …

Boston Scientific percutaneous catheters focus of FDA safety alert

[Nurse opening sterile package containing iv catheter in hospital setting] Carmen Ruiz alonso/iStock via Getty Images * The US FDA is recommending that certain lots of Boston Scientific's (BSX [https://seekingalpha.com/symbol/BSX]) ENROUTE Transcarotid Neuroprotection System percutaneous catheters be avoided following reports of arterial sheath tip …

Boston Scientific (BSX) Q2 Earnings on the Horizon: Analysts' Insights on Key Performance Measures

The upcoming report from Boston Scientific (BSX) is expected to reveal quarterly earnings of $0.83 per share, indicating an increase of 10.7% compared to the year-ago period. Analysts forecast revenues of $5.39 billion, representing an increase of 6.5% year over year. Over the last …

Boston Scientific (BSX) Enrolls First Patients In Global Faraflex AFib Trial

Find winning stocks in any market cycle. Join 7 million investors using Simply Wall St's investing ideas for FREE. Boston Scientific (NYSE:BSX) has enrolled the first patients in the global FARADIGM trial. The study evaluates the Faraflex pulsed field ablation device for the treatment …

Boston Scientific (BSX) Stock Still Looks Undervalued Following Its 58% Slump

Get insights on thousands of stocks from the global community of over 7 million individual investors at Simply Wall St. Boston Scientific stock has had a tough run over the past year, yet the valuation checks still lean supportive, setting up a clear tension …

Boston Scientific (BSX) Recalls Put Focus On Whether The Stock Still Looks Undervalued

Get insights on thousands of stocks from the global community of over 7 million individual investors at Simply Wall St. Recall driven attention on Boston Scientific stock Boston Scientific (BSX) is back in focus after a series of voluntary recalls for its CRE and …

Boston Scientific (BSX) Stock Sinks As Market Gains: What You Should Know

Boston Scientific (BSX) closed at $43.19 in the latest trading session, marking a -1.33% move from the prior day. This change lagged the S&P 500's daily gain of 0.89%. At the same time, the Dow added 0.74%, and the tech-heavy Nasdaq gained 1.29%. Shares …

Boston Scientific Aktie: 65% Kurspotenzial trotz anhaltender Talfahrt

Aktie von Boston Scientific fällt um 10 % – Schwäche bei Watchman-Implantaten und Wettbewerbsdruck belasten

Boston Scientific Stock Near 52-Week Lows: Why Analysts Still See a 60% Upside for 2026

Boston Scientific Stock: Is the EP Share Loss Fear Creating a 60% Mispricing Right Now?

Boston Scientific-Aktie: Solide Zahlen, schwacher Ausblick!

Boston Scientific Fell 28% in 2026, Do Analysts See Recovery?

Boston Scientific-Aktie: Ist die Wachstumsstory vorbei?

Down 10% In Last 12 Months, Can Boston Scientific Stock Recover Through 2027?

Boston Scientific Stock Prediction: Where Analysts See the Stock Going by 2027

Boston Scientific Corporation: Finanzdaten Prognosen Schätzungen und Erwartungen | 884113 | US1011371077